Equities analysts expect that Cerner Co. (NASDAQ:CERN) will report sales of $1.34 billion for the current quarter, Zacks Investment Research reports. Ten analysts have made estimates for Cerner’s earnings, with estimates ranging from $1.31 billion to $1.35 billion. Cerner posted sales of $1.26 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 6.3%. The company is expected to announce its next earnings report on Thursday, April 26th.
According to Zacks, analysts expect that Cerner will report full-year sales of $1.34 billion for the current fiscal year, with estimates ranging from $5.45 billion to $5.61 billion. For the next year, analysts expect that the business will report sales of $6.02 billion per share, with estimates ranging from $5.88 billion to $6.16 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that cover Cerner.
Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.61 EPS.
In other news, Vice Chairman Clifford W. Illig sold 307,700 shares of the business’s stock in a transaction on Thursday, March 8th. The shares were sold at an average price of $64.52, for a total transaction of $19,852,804.00. Following the completion of the transaction, the insider now owns 1,229,719 shares of the company’s stock, valued at $79,341,469.88. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Jeffrey A. Townsend sold 230,000 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $61.94, for a total transaction of $14,246,200.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 541,800 shares of company stock valued at $34,353,860. 13.11% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the company. Icon Wealth Partners LLC acquired a new position in shares of Cerner during the fourth quarter valued at $107,000. Fuller & Thaler Asset Management Inc. acquired a new position in shares of Cerner during the third quarter valued at $121,000. Cerebellum GP LLC acquired a new position in shares of Cerner during the fourth quarter valued at $127,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Cerner during the third quarter valued at $128,000. Finally, Delpha Capital Management LLC acquired a new position in shares of Cerner during the fourth quarter valued at $144,000. 78.56% of the stock is owned by institutional investors.
Shares of Cerner (CERN) opened at $63.05 on Wednesday. The stock has a market cap of $21,499.09, a P/E ratio of 24.53, a PEG ratio of 1.88 and a beta of 0.93. Cerner has a 12 month low of $54.49 and a 12 month high of $73.86. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.99 and a current ratio of 3.01.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2018/03/14/cerner-co-cern-expected-to-announce-quarterly-sales-of-1-34-billion-2.html.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.